Case Control Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jan 14, 2015; 21(2): 511-516
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.511
Figure 1
Figure 1 Differential expression of microRNA-103 levels in the serum of patients with nonalcoholic fatty liver disease. microRNA (miR)-103 was log-transformed before analysis because it was not normally distributed. aP < 0.05 vs normal control group (unpaired Student t test). NAFLD: Nonalcoholic fatty liver disease.